Literature DB >> 11524422

The complete pathway for catalytic activation of the mitogen-activated protein kinase, ERK2.

C N Prowse1, M S Deal, J Lew.   

Abstract

The mitogen-activated protein (MAP) kinase ERK2 is an essential signal transduction molecule that mediates extracellular signaling by all polypeptide growth factors. Full activation of ERK2 requires phosphorylation at both a threonine residue (Thr(183)) conserved in most protein kinases as well as a tyrosine residue (Tyr(185)) unique to members of the mitogen-activated protein kinase family. We have characterized the kinetic role of phosphorylation at each site with respect to the overall activation mechanism, providing a complete picture of the reaction steps involved. Phosphorylation at Tyr(185) serves to configure the ATP binding site, while phosphorylation at both residues is required to stabilize binding of the protein substrate, myelin basic protein. Similar control mechanisms are employed to stabilize ATP and myelin basic protein in the phosphoryl group transfer reaction, accounting for the enormous increase in turnover rate. The mechanism of ERK2 activation is kinetically similar to that of the cell cycle control protein, cdk2/cyclinA. Phosphorylation of Tyr(185) in ERK2 and association of cyclinA with cdk2 both serve to stabilize ATP binding. Subsequent phosphorylation of both enzymes on threonine serves to stabilize binding of the phosphoacceptor substrate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11524422     DOI: 10.1074/jbc.M105860200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  The molecular features of chromosome pairing at meiosis: the polyploid challenge using wheat as a reference.

Authors:  Faridoon K Yousafzai; Nadia Al-Kaff; Graham Moore
Journal:  Funct Integr Genomics       Date:  2010-04-27       Impact factor: 3.410

2.  Contribution of non-catalytic core residues to activity and regulation in protein kinase A.

Authors:  Jie Yang; Eileen J Kennedy; Jian Wu; Michael S Deal; Juniper Pennypacker; Gourisankar Ghosh; Susan S Taylor
Journal:  J Biol Chem       Date:  2009-01-02       Impact factor: 5.157

3.  Inference of Multisite Phosphorylation Rate Constants and Their Modulation by Pathogenic Mutations.

Authors:  Eyan Yeung; Sarah McFann; Lewis Marsh; Emilie Dufresne; Sarah Filippi; Heather A Harrington; Stanislav Y Shvartsman; Martin Wühr
Journal:  Curr Biol       Date:  2020-02-13       Impact factor: 10.834

4.  The WW domain of the scaffolding protein IQGAP1 is neither necessary nor sufficient for binding to the MAPKs ERK1 and ERK2.

Authors:  A Jane Bardwell; Leonila Lagunes; Ronak Zebarjedi; Lee Bardwell
Journal:  J Biol Chem       Date:  2017-04-10       Impact factor: 5.157

5.  Combination of two activating mutations in one HOG1 gene forms hyperactive enzymes that induce growth arrest.

Authors:  Gilad Yaakov; Michal Bell; Stefan Hohmann; David Engelberg
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

6.  Phosphorylation or Mutation of the ERK2 Activation Loop Alters Oligonucleotide Binding.

Authors:  Andrea C McReynolds; Aroon S Karra; Yan Li; Elias Daniel Lopez; Adrian G Turjanski; Elhadji Dioum; Kristina Lorenz; Elma Zaganjor; Steve Stippec; Kathleen McGlynn; Svetlana Earnest; Melanie H Cobb
Journal:  Biochemistry       Date:  2016-03-16       Impact factor: 3.162

7.  Evolutionary constraints associated with functional specificity of the CMGC protein kinases MAPK, CDK, GSK, SRPK, DYRK, and CK2alpha.

Authors:  Natarajan Kannan; Andrew F Neuwald
Journal:  Protein Sci       Date:  2004-08       Impact factor: 6.725

8.  Structure-Based Assignment of Ile, Leu, and Val Methyl Groups in the Active and Inactive Forms of the Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase 2.

Authors:  Yao Xiao; Lisa R Warner; Michael P Latham; Natalie G Ahn; Arthur Pardi
Journal:  Biochemistry       Date:  2015-07-13       Impact factor: 3.162

Review 9.  Mutations That Confer Drug-Resistance, Oncogenicity and Intrinsic Activity on the ERK MAP Kinases-Current State of the Art.

Authors:  Karina Smorodinsky-Atias; Nadine Soudah; David Engelberg
Journal:  Cells       Date:  2020-01-06       Impact factor: 6.600

10.  Sensing domain dynamics in protein kinase A-I{alpha} complexes by solution X-ray scattering.

Authors:  Cecilia Y Cheng; Jie Yang; Susan S Taylor; Donald K Blumenthal
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.